A chalcone derivative SBD-2 exerts anticancer effects in human colorectal cancer cells

IF 3.4 Q2 PHARMACOLOGY & PHARMACY Future Journal of Pharmaceutical Sciences Pub Date : 2024-08-06 DOI:10.1186/s43094-024-00672-8
Bowen Zheng, Wanjun Lin, Na Zhang, Xiaoming Huang, Jingjing Du, Yunfu Shen, Junhe Chen, Qianyu Lin, Zhuya Yang, Wenzhe Ma
{"title":"A chalcone derivative SBD-2 exerts anticancer effects in human colorectal cancer cells","authors":"Bowen Zheng,&nbsp;Wanjun Lin,&nbsp;Na Zhang,&nbsp;Xiaoming Huang,&nbsp;Jingjing Du,&nbsp;Yunfu Shen,&nbsp;Junhe Chen,&nbsp;Qianyu Lin,&nbsp;Zhuya Yang,&nbsp;Wenzhe Ma","doi":"10.1186/s43094-024-00672-8","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>In this study, the potential anticancer activity and mechanism of action of SBD-2, a chalcone isolated from <i>Shuteria involucrata</i>, was investigated in colorectal cancer (CRC) cells.</p><h3>Results</h3><p>SBD-2 inhibited the proliferation of Caco-2 cells in a dose-dependent manner. It elicited the cells arrested in the G2/M phase and induced apoptosis. Mechanistically, SBD-2 inhibited Akt phosphorylation, which suppressed the ani-apoptotic protein Bcl-2 and cell cycle regulator Cyclin B1, leading to apoptosis ad cycle arrest, respectively.</p><h3>Conclusions</h3><p>The presented chalcone compound SBD-2 from <i>Shuteria involucrata</i> induced apoptosis and cell cycle arrest through inhibiting Akt pathway, highlighting the possibility to develop as a new agent for CRC treatment.</p></div>","PeriodicalId":577,"journal":{"name":"Future Journal of Pharmaceutical Sciences","volume":"10 1","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://fjps.springeropen.com/counter/pdf/10.1186/s43094-024-00672-8","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Journal of Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://link.springer.com/article/10.1186/s43094-024-00672-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

In this study, the potential anticancer activity and mechanism of action of SBD-2, a chalcone isolated from Shuteria involucrata, was investigated in colorectal cancer (CRC) cells.

Results

SBD-2 inhibited the proliferation of Caco-2 cells in a dose-dependent manner. It elicited the cells arrested in the G2/M phase and induced apoptosis. Mechanistically, SBD-2 inhibited Akt phosphorylation, which suppressed the ani-apoptotic protein Bcl-2 and cell cycle regulator Cyclin B1, leading to apoptosis ad cycle arrest, respectively.

Conclusions

The presented chalcone compound SBD-2 from Shuteria involucrata induced apoptosis and cell cycle arrest through inhibiting Akt pathway, highlighting the possibility to develop as a new agent for CRC treatment.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
一种查尔酮衍生物 SBD-2 在人类结直肠癌细胞中发挥抗癌作用
本研究调查了 SBD-2 在结直肠癌(CRC)细胞中的潜在抗癌活性和作用机制,SBD-2 是一种从 Shuteria involucrata 中分离出来的查尔酮。SBD-2 以剂量依赖的方式抑制了 Caco-2 细胞的增殖。它能使细胞停滞在 G2/M 期,并诱导细胞凋亡。从机理上讲,SBD-2 可抑制 Akt 磷酸化,从而抑制细胞凋亡蛋白 Bcl-2 和细胞周期调节因子 Cyclin B1,分别导致细胞凋亡和周期停滞。本研究介绍的梭梭属内卷卷叶查尔酮化合物 SBD-2 通过抑制 Akt 通路诱导细胞凋亡和细胞周期停滞,有望开发成治疗 CRC 的新药。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
44
审稿时长
23 weeks
期刊介绍: Future Journal of Pharmaceutical Sciences (FJPS) is the official journal of the Future University in Egypt. It is a peer-reviewed, open access journal which publishes original research articles, review articles and case studies on all aspects of pharmaceutical sciences and technologies, pharmacy practice and related clinical aspects, and pharmacy education. The journal publishes articles covering developments in drug absorption and metabolism, pharmacokinetics and dynamics, drug delivery systems, drug targeting and nano-technology. It also covers development of new systems, methods and techniques in pharmacy education and practice. The scope of the journal also extends to cover advancements in toxicology, cell and molecular biology, biomedical research, clinical and pharmaceutical microbiology, pharmaceutical biotechnology, medicinal chemistry, phytochemistry and nutraceuticals.
期刊最新文献
Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod Development, characterization, and assessment of PLAROsomal vesicular system of curcumin for enhanced stability and therapeutic efficacy Biogenic synthesis of silver nanoparticles from Hylocereus undatus peel waste: exploring EGFR inhibition for targeted therapy of cervical and breast carcinomas Metabolic syndrome severity z-score in non-diabetic non-obese Egyptian patients with chronic hepatitis c virus infection Molecular modeling and implications of Biochanin A on ghrelin and IGF-1/myostatin signaling in radiation triggered cachexia
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1